Baseline characteristics of entire cohort
| . | N . | % . |
|---|---|---|
| Age at diagnosis, y | ||
| <60 | 57 | 37 |
| >60 | 96 | 63 |
| Sex | ||
| Female | 83 | 54 |
| Male | 70 | 46 |
| Race | ||
| White | 137 | 90 |
| Black/Hispanic | 8 | 5 |
| Asian | 8 | 5 |
| ECOG PS | ||
| 0-2 | 123 | 80 |
| 3-4 | 30 | 20 |
| MSKCC score | ||
| Low risk | 23 | 15 |
| Intermediate risk | 85 | 56 |
| High risk | 45 | 29 |
| Focality | ||
| Multifocal | 91 | 59 |
| Unifocal | 62 | 41 |
| COO | ||
| ABC | 82 | 78 |
| GCB | 23 | 22 |
| DEL | ||
| No | 49 | 56 |
| Yes | 39 | 44 |
| EBER ISH | ||
| Negative | 97 | 91 |
| Positive | 10 | 9 |
| . | N . | % . |
|---|---|---|
| Age at diagnosis, y | ||
| <60 | 57 | 37 |
| >60 | 96 | 63 |
| Sex | ||
| Female | 83 | 54 |
| Male | 70 | 46 |
| Race | ||
| White | 137 | 90 |
| Black/Hispanic | 8 | 5 |
| Asian | 8 | 5 |
| ECOG PS | ||
| 0-2 | 123 | 80 |
| 3-4 | 30 | 20 |
| MSKCC score | ||
| Low risk | 23 | 15 |
| Intermediate risk | 85 | 56 |
| High risk | 45 | 29 |
| Focality | ||
| Multifocal | 91 | 59 |
| Unifocal | 62 | 41 |
| COO | ||
| ABC | 82 | 78 |
| GCB | 23 | 22 |
| DEL | ||
| No | 49 | 56 |
| Yes | 39 | 44 |
| EBER ISH | ||
| Negative | 97 | 91 |
| Positive | 10 | 9 |
DEL, double-expressor lymphoma; EBER ISH, Epstein-Barr encoding region in situ hybridization; GCB, germinal center B cell.